Annual ROA
-44.70%
-8.34%-22.94%
31 December 2023
Summary:
Allogene Therapeutics annual return on assets is currently -44.70%, with the most recent change of -8.34% (-22.94%) on 31 December 2023. During the last 3 years, it has fallen by -18.93% (-73.46%). ALLO annual ROA is now -158.08% below its all-time high of -17.32%, reached on 31 December 2021.ALLO ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROA
-45.99%
-2.81%-6.51%
30 September 2024
Summary:
Allogene Therapeutics quarterly return on assets is currently -45.99%, with the most recent change of -2.81% (-6.51%) on 30 September 2024. Over the past year, it has dropped by -2.31% (-5.29%). ALLO quarterly ROA is now -180.09% below its all-time high of -16.42%, reached on 31 December 2021.ALLO Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALLO ROA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -22.9% | -5.3% |
| 3 y3 years | -73.5% | -67.4% |
| 5 y5 years | -63.6% | -120.4% |
ALLO ROA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -158.1% | at low | -180.1% | at low |
| 5 y | 5 years | -158.1% | at low | -180.1% | at low |
| alltime | all time | -158.1% | at low | -180.1% | +6.7% |
Allogene Therapeutics ROA History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -45.99%(+6.5%) |
| June 2024 | - | -43.18%(+2.2%) |
| Mar 2024 | - | -42.25%(-4.6%) |
| Dec 2023 | -44.70%(+22.9%) | -44.29%(+1.4%) |
| Sept 2023 | - | -43.68%(-0.1%) |
| June 2023 | - | -43.71%(+5.9%) |
| Mar 2023 | - | -41.27%(+13.3%) |
| Dec 2022 | -36.36%(+109.9%) | -36.43%(+51.1%) |
| Sept 2022 | - | -24.11%(+7.1%) |
| June 2022 | - | -22.51%(+6.2%) |
| Mar 2022 | - | -21.19%(+29.0%) |
| Dec 2021 | -17.32% | -16.42%(-40.2%) |
| Sept 2021 | - | -27.48%(+7.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2021 | - | -25.64%(+6.3%) |
| Mar 2021 | - | -24.13%(-16.2%) |
| Dec 2020 | -25.77%(+0.2%) | -28.78%(+15.3%) |
| Sept 2020 | - | -24.97%(-7.7%) |
| June 2020 | - | -27.05%(-7.6%) |
| Mar 2020 | - | -29.27%(+14.8%) |
| Dec 2019 | -25.72%(-5.9%) | -25.49%(+22.1%) |
| Sept 2019 | - | -20.87%(-4.3%) |
| June 2019 | - | -21.81%(-48.8%) |
| Mar 2019 | - | -42.62%(+1.3%) |
| Dec 2018 | -27.33% | -42.08%(-14.7%) |
| Sept 2018 | - | -49.31%(+7.2%) |
| June 2018 | - | -46.01% |
FAQ
- What is Allogene Therapeutics annual return on assets?
- What is the all time high annual ROA for Allogene Therapeutics?
- What is Allogene Therapeutics annual ROA year-on-year change?
- What is Allogene Therapeutics quarterly return on assets?
- What is the all time high quarterly ROA for Allogene Therapeutics?
- What is Allogene Therapeutics quarterly ROA year-on-year change?
What is Allogene Therapeutics annual return on assets?
The current annual ROA of ALLO is -44.70%
What is the all time high annual ROA for Allogene Therapeutics?
Allogene Therapeutics all-time high annual return on assets is -17.32%
What is Allogene Therapeutics annual ROA year-on-year change?
Over the past year, ALLO annual return on assets has changed by -8.34% (-22.94%)
What is Allogene Therapeutics quarterly return on assets?
The current quarterly ROA of ALLO is -45.99%
What is the all time high quarterly ROA for Allogene Therapeutics?
Allogene Therapeutics all-time high quarterly return on assets is -16.42%
What is Allogene Therapeutics quarterly ROA year-on-year change?
Over the past year, ALLO quarterly return on assets has changed by -2.31% (-5.29%)